Medical Application Of Resminostat In Asian Patients


Ontology type: sgo:Patent     


Patent Info

DATE

N/A

AUTHORS

GRÖPPEL, Manfred

ABSTRACT

The invention relates to medical applications of the HDAC inhibitor resminostat ((E)-3-[1-{4-Dimethylaminomethyl-benzenesulfonyl)-1H-pyrroi-3-yl]-N-hydroxy-acrylamide) or a salt or solvate thereof in the treatment of benign or malignant neoplasia in a human subject, wherein said human subject is an Asian, and wherein said treatment comprises administering resminostat or a salt or solvate thereof to said human subiect in a daily dose of less than 600 mg resminostat, and administering at least one further chemotherapeutic agent to said human subject. More... »

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3053", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "name": "GR\u00d6PPEL, Manfred", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1002/ijc.20372", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003553052"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1038/clpt.2008.144", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017753984"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/cts.12386", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023598033"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/cas.12647", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032691284"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jhep.2016.02.043", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047462306"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10637-017-0435-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074245965", 
          "https://doi.org/10.1007/s10637-017-0435-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10637-017-0435-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074245965", 
          "https://doi.org/10.1007/s10637-017-0435-2"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "description": "

The invention relates to medical applications of the HDAC inhibitor resminostat ((E)-3-[1-{4-Dimethylaminomethyl-benzenesulfonyl)-1H-pyrroi-3-yl]-N-hydroxy-acrylamide) or a salt or solvate thereof in the treatment of benign or malignant neoplasia in a human subject, wherein said human subject is an Asian, and wherein said treatment comprises administering resminostat or a salt or solvate thereof to said human subiect in a daily dose of less than 600 mg resminostat, and administering at least one further chemotherapeutic agent to said human subject.

", "id": "sg:patent.WO-2017178577-A1", "keywords": [ "medical application", "invention", "HDAC inhibitor", "acrylamide", "salt", "wherein", "Asian Continental Ancestry Group", "human", "dose", "chemotherapeutic agent" ], "name": "MEDICAL APPLICATION OF RESMINOSTAT IN ASIAN PATIENTS", "recipient": [ { "id": "https://www.grid.ac/institutes/grid.434484.b", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/WO-2017178577-A1" ], "sdDataset": "patents", "sdDatePublished": "2019-03-07T15:37", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com.uberresearch.data.dev.patents-pipeline/full_run_10/sn-export/5eb3e5a348d7f117b22cc85fb0b02730/0000100128-0000348334/json_export_ec415531.jsonl", "type": "Patent" } ]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.WO-2017178577-A1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.WO-2017178577-A1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.WO-2017178577-A1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.WO-2017178577-A1'


 

This table displays all metadata directly associated to this object as RDF triples.

50 TRIPLES      14 PREDICATES      29 URIs      17 LITERALS      2 BLANK NODES

Subject Predicate Object
1 sg:patent.WO-2017178577-A1 schema:about anzsrc-for:3053
2 schema:author N46f7e35ae079421782c952a283c2363f
3 schema:citation sg:pub.10.1007/s10637-017-0435-2
4 https://doi.org/10.1002/ijc.20372
5 https://doi.org/10.1016/j.jhep.2016.02.043
6 https://doi.org/10.1038/clpt.2008.144
7 https://doi.org/10.1111/cas.12647
8 https://doi.org/10.1111/cts.12386
9 schema:description <p num="0000">The invention relates to medical applications of the HDAC inhibitor resminostat ((E)-3-[1-{4-Dimethylaminomethyl-benzenesulfonyl)-1H-pyrroi-3-yl]-N-hydroxy-acrylamide) or a salt or solvate thereof in the treatment of benign or malignant neoplasia in a human subject, wherein said human subject is an Asian, and wherein said treatment comprises administering resminostat or a salt or solvate thereof to said human subiect in a daily dose of less than 600 mg resminostat, and administering at least one further chemotherapeutic agent to said human subject.</p>
10 schema:keywords Asian Continental Ancestry Group
11 HDAC inhibitor
12 acrylamide
13 chemotherapeutic agent
14 dose
15 human
16 invention
17 medical application
18 salt
19 wherein
20 schema:name MEDICAL APPLICATION OF RESMINOSTAT IN ASIAN PATIENTS
21 schema:recipient https://www.grid.ac/institutes/grid.434484.b
22 schema:sameAs https://app.dimensions.ai/details/patent/WO-2017178577-A1
23 schema:sdDatePublished 2019-03-07T15:37
24 schema:sdLicense https://scigraph.springernature.com/explorer/license/
25 schema:sdPublisher Nf565c88b2cf54f2e8b88d89c1a4d12dd
26 sgo:license sg:explorer/license/
27 sgo:sdDataset patents
28 rdf:type sgo:Patent
29 N46f7e35ae079421782c952a283c2363f rdf:first Nc23a8110036245b3a732cd66994182f9
30 rdf:rest rdf:nil
31 Nc23a8110036245b3a732cd66994182f9 schema:name GRÖPPEL, Manfred
32 rdf:type schema:Person
33 Nf565c88b2cf54f2e8b88d89c1a4d12dd schema:name Springer Nature - SN SciGraph project
34 rdf:type schema:Organization
35 anzsrc-for:3053 schema:inDefinedTermSet anzsrc-for:
36 rdf:type schema:DefinedTerm
37 sg:pub.10.1007/s10637-017-0435-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074245965
38 https://doi.org/10.1007/s10637-017-0435-2
39 rdf:type schema:CreativeWork
40 https://doi.org/10.1002/ijc.20372 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003553052
41 rdf:type schema:CreativeWork
42 https://doi.org/10.1016/j.jhep.2016.02.043 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047462306
43 rdf:type schema:CreativeWork
44 https://doi.org/10.1038/clpt.2008.144 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017753984
45 rdf:type schema:CreativeWork
46 https://doi.org/10.1111/cas.12647 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032691284
47 rdf:type schema:CreativeWork
48 https://doi.org/10.1111/cts.12386 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023598033
49 rdf:type schema:CreativeWork
50 https://www.grid.ac/institutes/grid.434484.b schema:Organization
 




Preview window. Press ESC to close (or click here)


...